Summary
This prediction is currently active. The BUY prediction by melinda for Bayer AG is performing very badly with a performance of -43.38%. A total of €0.12 was paid as dividends for this prediction. This prediction currently runs until 10.07.24. The prediction end date can be changed by melinda at any time. melinda has 20% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bayer AG | 2.457% | 2.457% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
According to melinda what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year